Journal of Dual Diagnosis
Scope & Guideline
Transforming perspectives on mental health and addiction.
Introduction
Aims and Scopes
- Co-occurring Disorders Research:
The journal publishes studies on the prevalence, characteristics, and treatment of individuals suffering from both mental health disorders and substance use disorders, highlighting their interconnectedness. - Clinical Interventions and Treatment Strategies:
It focuses on evidence-based practices and innovative treatment approaches aimed at improving outcomes for patients with dual diagnoses, including pharmacological, psychological, and psychosocial interventions. - Impact of Trauma and Stress on Substance Use:
Research exploring the role of trauma, particularly post-traumatic stress disorder (PTSD), in the development and exacerbation of substance use disorders is a core area of focus. - Demographic and Sociocultural Influences:
The journal examines how various demographic factors, such as race, gender, and socioeconomic status, influence the manifestation and treatment of dual diagnosis, aiming to address health disparities. - Public Health Perspectives:
It contributes to the discourse on public health implications of dual diagnosis, including policy impacts and community health strategies, particularly in the context of emerging issues like the COVID-19 pandemic.
Trending and Emerging
- Impact of COVID-19 on Substance Use and Mental Health:
A significant number of recent studies have focused on how the COVID-19 pandemic has affected substance use patterns and mental health outcomes, showcasing the urgent need to adapt treatment and support mechanisms during public health crises. - Use of Technology in Treatment Delivery:
There is an increasing trend towards exploring digital interventions and telehealth solutions for managing dual diagnosis, indicating a shift towards modernizing treatment approaches to improve accessibility and engagement. - Understanding Trauma's Role in Dual Diagnosis:
Emerging research emphasizes the complexities of trauma in relation to substance use and mental health disorders, with a focus on tailored interventions addressing trauma-related symptoms. - Cultural and Racial Considerations in Treatment:
Recent publications have highlighted the importance of understanding cultural and racial factors in the treatment of dual diagnosis, striving for more inclusive and equitable healthcare practices. - Innovative Treatment Modalities:
The exploration of integrative treatment models, such as harm reduction and holistic approaches, is gaining traction, reflecting a broader acceptance of diverse strategies to address the multifaceted nature of dual diagnosis.
Declining or Waning
- Traditional Substance Use Treatment Models:
There appears to be a waning emphasis on conventional treatment models that do not integrate mental health services, as newer studies increasingly advocate for holistic, dual-focused approaches. - Single Disorder Studies:
Research focusing exclusively on either substance use disorders or mental health conditions, without considering their co-occurrence, is becoming less frequent, indicating a shift towards more integrated research frameworks. - Generalized Risk Factors without Contextual Analysis:
There is a decline in studies that discuss risk factors for substance use or mental health disorders in isolation, suggesting a preference for more nuanced analyses that consider the interplay of various factors in dual diagnosis. - Static Epidemiological Studies:
Epidemiological studies that do not address contemporary issues, such as the impact of recent societal changes or the pandemic on dual diagnosis, are less represented, indicating a need for more dynamic and contextually relevant research. - Focus on Non-Evidence-Based Interventions:
Research centered on interventions lacking rigorous evidence or those that do not demonstrate efficacy in dual diagnosis contexts is decreasing, as the journal prioritizes high-quality, evidence-based studies.
Similar Journals
PSYCHOLOGICAL MEDICINE
Fostering innovation in psychiatric science.PSYCHOLOGICAL MEDICINE is a leading journal in the field of psychiatry and psychology, published by Cambridge University Press. With its ISSN 0033-2917 and E-ISSN 1469-8978, this journal has firmly established itself as a premier platform for cutting-edge research since its inception in 1970. It consistently ranks in the top quartile for both Applied Psychology and Psychiatry and Mental Health, reflecting its exceptional impact in the field, with a 2023 Scopus ranking of #36 out of 567 in Psychiatry and Mental Health, and #21 out of 249 in Applied Psychology. The journal aims to publish comprehensive studies that explore the interplay between psychological phenomena and medical health, contributing vital insights that advance both theoretical understanding and clinical practice. Although it is not an Open Access journal, PSYCHOLOGICAL MEDICINE remains a vital resource for researchers, professionals, and students committed to the scientific investigation of mental health issues.
Canadian Journal of Addiction
Innovating solutions for a healthier society.Canadian Journal of Addiction is a leading platform dedicated to advancing the understanding of addiction and its multifaceted impacts on individuals and society. Published by LIPPINCOTT WILLIAMS & WILKINS, this journal aims to foster rigorous research and discussion in the field of addiction studies, contributing significantly to the intersection of psychiatry and mental health. With its ISSN 2368-4720 and E-ISSN 2368-4739, the journal is indexed in Scopus and has been categorized in the Q3 quartile for 2023, reflecting its emerging influence amongst peers. The Canadian Journal of Addiction facilitates a vital exchange of ideas and findings, crucial for researchers, practitioners, and students alike, addressing pressing issues related to addiction through innovative studies and insightful reviews. Subscribers and readers benefit from the latest findings as they navigate through the dynamic landscape of addiction research, enriching both academic knowledge and practical applications.
JOURNAL OF ADDICTIVE DISEASES
Elevating the Discourse on Addictive DiseasesJOURNAL OF ADDICTIVE DISEASES, published by ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD, serves as a pivotal platform for researchers, clinicians, and students in the realms of clinical psychology, psychiatry, and addiction studies. With a distinguished history dating back to its inception in 1991, this journal spans critical research developments with its current scope covering converged years from 2018 to 2024, ensuring a robust repository of knowledge. Notably, it holds a respectable impact factor and is categorized in Q2 quartiles across several disciplines including Clinical Psychology, Medicine (miscellaneous), and Psychiatry and Mental Health for 2023, reflecting its impactful contributions to the scientific community. Despite the journal not currently offering Open Access, it remains highly ranked, occupying positions in the top percentiles of Scopus rankings. This journal emphasizes the importance of disseminating high-quality research focused on addictive behaviors and diseases, thereby addressing vital clinical and public health challenges.
Substance Abuse
Advancing knowledge in substance use disorders.Substance Abuse is a premier scholarly journal published by SAGE Publications Inc, dedicated to advancing the understanding and treatment of substance use disorders. With an established presence from 1995 to 2023, the journal boasts an impressive Q1 ranking in both Medicine (miscellaneous) and Psychiatry and Mental Health, positioning it among the top tier of academic publications in these fields. Researchers and professionals will find its articles, which are grounded in rigorous empirical studies and innovative interventions, essential for addressing the complex and multifaceted nature of substance abuse. Although not an open access publication, Substance Abuse maintains a commitment to sharing valuable insights and findings, making it a vital resource for those looking to enhance their knowledge and practice. Located in Thousand Oaks, CA, this journal serves as a critical forum for international dialogue and research dissemination, ensuring that current trends and challenges in substance use are thoughtfully examined and discussed within the academic community.
ADDICTIVE BEHAVIORS
Unraveling the Complexities of AddictionADDICTIVE BEHAVIORS is a prestigious journal published by PERGAMON-ELSEVIER SCIENCE LTD, specializing in the critical examination and exploration of addiction-related issues across diverse fields including Clinical Psychology, Psychiatry and Mental Health, and Toxicology. With a robust history dating back to 1975 and convergence extending to 2024, the journal is esteemed for its rigorous peer-reviewed research that contributes significantly to understanding addiction phenomena. Ranked in the Q1 category for its focus areas, it stands out within the academic community, evidenced by its impressive Scopus rankings—25th in Clinical Psychology and 14th in Toxicology—placing it in the top tier of its disciplines. This journal offers valuable insights into addiction behaviors, treatment methodologies, and public health implications, making it an essential resource for researchers, practitioners, and students seeking to advance their knowledge and impact the field. Although not Open Access, it provides vital access options for institutions and individuals invested in addiction studies.
Suchttherapie
Transforming Therapeutic Approaches to AddictionSuchttherapie, an esteemed journal published by GEORG THIEME VERLAG KG, serves as a critical platform within the fields of Applied Psychology and Psychiatry and Mental Health. Established in 2000 and continuing through 2024, this journal is committed to advancing the understanding and treatment of addiction and related psychological issues. Although it currently stands in the Q4 Quartile ranking and is categorized as low percentile in both Scopus Ranks and impact metrics, its significance lies in its dedication to disseminating cutting-edge research and clinical findings that contribute to the evolving landscape of therapeutic practices. Published in Germany, the journal facilitates unlimited access to the vital discourse surrounding mental health and addiction treatment, making it a valuable resource for researchers, professionals, and students alike seeking to enhance their knowledge and skills in this important area of study. As the field continues to grow, Suchttherapie plays a pivotal role in bridging practice with academic rigor, ensuring that readers remain informed on the latest methodologies and insights.
Asia-Pacific Psychiatry
Pioneering Research in Asia-Pacific Mental HealthAsia-Pacific Psychiatry is a leading academic journal published by WILEY, focused on the diverse and rapidly evolving fields of psychiatry and mental health within the Asia-Pacific region. With an ISSN of 1758-5864 and an E-ISSN of 1758-5872, this journal has been recognized for its significant impact, holding a Q1 ranking in Medicine (miscellaneous) and a Q2 ranking in Psychiatry and Mental Health as of 2023. Its commendable Scopus ranking places it at Rank #83 out of 567 in its category, highlighting its influence and relevance in contemporary research. The journal aims to facilitate the dissemination of high-quality research, reviews, and clinical insights that address mental health challenges, promote global understanding, and encourage collaboration among professionals and academics. Although it is not an open-access journal, the high impact factor underscores its value in the scholarly community, making it an essential resource for researchers, clinicians, and students dedicated to enhancing mental health practices and policies in the region and beyond.
Therapeutic Communities
Connecting professionals through vital mental health research.Therapeutic Communities, a publication of EMERALD GROUP PUBLISHING LTD, has been a significant contributor to the fields of clinical psychology, psychiatry, and mental health since its inception in 1992. With the ISSN 0964-1866 and E-ISSN 2052-4730, this journal aims to disseminate innovative research and comprehensive reviews that advance our understanding of therapeutic communities and their impact on psychological well-being. Although currently ranked in the Q4 category for Clinical Psychology and Health Professions, the journal continues to strive towards elevating scholarly discourse and practice in mental health settings. Located in the United Kingdom, the journal does not offer open access, but its content remains vital for researchers and practitioners seeking to explore therapeutic modalities and community-based interventions. As the landscape of mental health care evolves, Therapeutic Communities stands as a crucial platform for sharing insights and fostering collaboration among professionals in this essential domain.
DRUG AND ALCOHOL REVIEW
Advancing understanding of substance use and addiction.DRUG AND ALCOHOL REVIEW, published by Wiley, is a leading journal dedicated to advancing the scholarship in the fields of drug and alcohol research. Since its inception in 1989, this esteemed publication has provided a critical platform for the dissemination of innovative research findings, reviews, and theoretical papers, addressing pressing issues in substance use and addiction. With an impact factor that places it in the Q1 category in both Health (social science) and Medicine (miscellaneous), it ranks #78 out of 371 in the Scopus index for Health and #115 out of 398 in Medicine, reflecting its significant influence and high citation rates among scholars. The journal is committed to fostering a multidisciplinary approach, integrating perspectives from psychology, sociology, public health, and medicine, to inform policy and practice. Accessible to researchers and practitioners alike, *DRUG AND ALCOHOL REVIEW* serves as an essential resource for anyone invested in understanding and addressing the complexities of drug and alcohol use in society.
Middle East Current Psychiatry-MECPsych
Innovating psychiatric practice through open access.Middle East Current Psychiatry (MECPsych), published by SpringerNature, is a prominent open-access journal dedicated to advancing the field of psychiatry and mental health in the Middle East and beyond. Since its establishment in 2011, MECPsych has aimed to disseminate high-quality research, reviews, and reports that capture recent developments in psychiatric science, clinical practice, and public health considerations in mental well-being. With an impact factor reflective of its growing influence and classified in the Q3 quartile for Psychiatry and Mental Health, the journal offers invaluable insights backed by rigorous peer review processes. Operating under an open access model since 2019, MECPsych ensures that its articles are freely accessible to a global readership, enhancing the visibility and application of research findings. As part of its ongoing commitment to enriching understanding in the field, MECPsych also encourages submissions that explore the unique cultural, societal, and economic factors influencing mental health across the region. This approach not only supports researchers, professionals, and students in their pursuit of knowledge but also fosters a collaborative dialogue among mental health stakeholders in the Middle East and around the world.